Plugging In To Improved Patient Care with Diabetes Technology
Image For Activity Cover
Credit Offered
No Credit Offered
  • Course Description
  • Learning Objectives
  • Accreditation Statement
  • Faculty and Disclosures
  • Recommended
Expert faculty will discuss:
  • Current guidelines, consensus statements, and playbooks on time in range
  • Strategies for the optimal use of CGM technology in the clinical setting
  • Expanding the use of diabetes technology in the COVID-19 era

This course was a virtual live CME-certified Ancillary Symposium presented at ENDO 2021. This educational activity is supported by an independent medical educational grant from Abbott Diabetes Care Inc.

This ancillary symposium is developed through the Endocrine Society’s Special Programs Committee (SPC).

Upon successful completion these educational sessions, participants should be better able to:

  1. Explain and interpret current guidelines, consensus statements, and playbooks on time in range
  2. Discuss and evaluate strategies for the optimal use of diabetes technology in practice
  3. Outline guidelines for use of CGM for COVID patients

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Nicole M. Ehrhardt, MD - Program Chair
Assistant Professor of Medicine
University of Washington Diabetes Institute
Seattle, WA

Richard M. Bergenstal, MD
Executive Director
International Diabetes Center, HealthPartners Institute
St. Louis Park, MN

Guillermo E. Umpierrez, MD
Professor of Medicine
Division of Endocrinology, Metabolism
Emory University School of Medicine
Chief of Diabetes and Endocrinology
Grady Health Systems
Atlanta, GA

Amisha Wallia, MD, MS
Assistant Professor of Medicine (Endocrinology)
Northwestern University
Chicago, IL

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The following faculty reported relevant financial relationships:
Nicole M. Ehrhardt, MD: Consultant, Novo Nordisk; Grant Recipient, Merck, Novo Nordisk; Research Investigator, Dexcom
Guillermo E. Umpierrez, MD: Research Investigator, Novo Nordisk, AstraZeneca, Dexcom
Amisha Wallia, MD, MS: Grant Recipient, Novo Nordisk; Research Investigator, Eli Lilly & Company, United Health Group

The following faculty reported no relevant financial relationships: 
Richard M. Bergenstal, MD

The following SPC member who planned and reviewed content for this activity reported no relevant financial relationships:  Beret Anne Casey, MD

The following SPC Committee members reported financial relationships:

  • Andjela T. Drincic, MD: Advisory Board Member, Corcept
  • Sergio Fazio, MD, PhD: Consultant, Amarin, Amgen, Akcea, Aegerion, Esperion, Novartis
  • Angela M. Leung, MD: Speaker, Medical Education Resources, MCE Conferences, ATA Board Member
  • Amy Rothberg, MD: Spouse, consultant of Merck
  • Katherine Araque, MD: Speaker, Novo Nordisk; Advisory Board, Corcept

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The following SPC members reported no relevant financial relationships:

Lorena Alarcon-Casas Wright, MD, Neena Natt, MD; Kelly Lauter Roszko, MD, PhD; Deborah Sellmeyer, MD; Savitha Subramanian, MD; Soleymani Taraneh, MD; Steven Weitzman, MD

The staff involved in the development of this CME activity reported no relevant financial relationships.

The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable

This educational activity is supported by an independent medical educational grant from Abbott Diabetes Care Inc.

     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
Powered By